
     RDKit          2D

 15 15  0  0  0  0  0  0  0  0999 V2000
    0.3627    0.8350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0718    1.2482    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3627    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3545   -0.4274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3464   -1.2482    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0719   -0.0199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7811   -0.4329    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0719    0.8151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3544    1.2425    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7892    1.2226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5065    0.7952    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0801   -0.4075    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.7892    0.0055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7892    0.8405    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5065   -0.4020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  6
  3  1  1  0
  3 12  1  6
  4  3  1  0
  4  5  1  1
  6  4  1  0
  6  7  1  6
  8  6  1  0
  8 10  1  1
  9  1  1  0
  9  8  1  0
 11 10  1  0
 13 12  1  0
 14 13  2  0
 15 13  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB03740

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT02319

>  <COMMON_NAME>  (1) 
N-acetyl-alpha-D-glucosamine

>  <CAS_NUMBER>  (1) 
10036-64-3

>  <UNII>  (1) 
T13TI5GH3D

>  <SYNONYMS>  (1) 
2-(acetylamino)-2-deoxy-A-D-glucopyranose; 2-(acetylamino)-2-deoxy-α-D-glucopyranose; N-acetyl-α-D-glucosamine; α-D-GlcNAc; α-GlcNAc

$$$$
